179 related articles for article (PubMed ID: 26116553)
1. Systematic Review with Meta-analysis of Prospective Studies: Anti-tumour Necrosis Factor for Prevention of Postoperative Crohn's Disease Recurrence.
Qiu Y; Mao R; Chen BL; He Y; Zeng ZR; Chen MH
J Crohns Colitis; 2015 Oct; 9(10):918-27. PubMed ID: 26116553
[TBL] [Abstract][Full Text] [Related]
2. Anti-TNF Agents and New Biological Agents (Vedolizumab and Ustekinumab) in the Prevention and Treatment of Postoperative Recurrence After Surgery in Crohn's Disease.
Gisbert JP; Chaparro M
Drugs; 2023 Sep; 83(13):1179-1205. PubMed ID: 37505446
[TBL] [Abstract][Full Text] [Related]
3. Antitumor necrosis factor α is more effective than conventional medical therapy for the prevention of postoperative recurrence of Crohn's disease: a meta-analysis.
Nguyen DL; Solaimani P; Nguyen ET; Jamal MM; Bechtold ML
Eur J Gastroenterol Hepatol; 2014 Oct; 26(10):1152-9. PubMed ID: 25089549
[TBL] [Abstract][Full Text] [Related]
4. Prevention and treatment of postoperative Crohn's disease recurrence with anti-TNF therapy: a meta-analysis of controlled trials.
Carla-Moreau A; Paul S; Roblin X; Genin C; Peyrin-Biroulet L
Dig Liver Dis; 2015 Mar; 47(3):191-6. PubMed ID: 25488057
[TBL] [Abstract][Full Text] [Related]
5. The Use of Vedolizumab in Preventing Postoperative Recurrence of Crohn's Disease.
Yamada A; Komaki Y; Patel N; Komaki F; Pekow J; Dalal S; Cohen RD; Cannon L; Umanskiy K; Smith R; Hurst R; Hyman N; Rubin DT; Sakuraba A
Inflamm Bowel Dis; 2018 Feb; 24(3):502-509. PubMed ID: 29462385
[TBL] [Abstract][Full Text] [Related]
6. Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results From the ENEIDA Registry.
Cañete F; Mañosa M; Casanova MJ; González-Sueyro RC; Barrio J; Bermejo F; Nos P; Iglesias-Flores E; García-Planella E; Pérez-Calle JL; Vicente R; Vera M; Ramos L; Rivero M; De Francisco R; Montserrat A; Benítez O; Navarro P; Taxonera C; Hinojosa E; Márquez-Mosquera L; Navarro-Llavat M; Ramírez-de la Piscina P; Gomollón F; Rodríguez-Alonso L; Núñez-Alonso A; Fernández-Salazar L; Almela P; Ríos León R; De Castro L; Gisbert JP; Ricart E; Cabré E; Domènech E;
Inflamm Bowel Dis; 2019 Oct; 25(11):1862-1870. PubMed ID: 31006801
[TBL] [Abstract][Full Text] [Related]
7. Biologics for the prevention of postoperative Crohn's disease recurrence: A systematic review and meta-analysis.
Zhao Y; Ma T; Chen YF; He XY; Ren LH; Chen J; Fang L; Su JW; Zhang HJ; Shi RH
Clin Res Hepatol Gastroenterol; 2015 Oct; 39(5):637-49. PubMed ID: 25958300
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Mesalazine, Thiopurines and Tumour Necrosis Factor Antagonists in Preventing Post-Operative Crohn's Disease Recurrence in a Real-Life Setting.
Allocca M; Landi R; Bonovas S; Fiorino G; Papa A; Spinelli A; Furfaro F; Peyrin-Biroulet L; Armuzzi A; Danese S
Digestion; 2017; 96(3):166-172. PubMed ID: 28903094
[TBL] [Abstract][Full Text] [Related]
9. Does anti-tumor necrosis factor alpha prevent the recurrence of Crohn's disease? Systematic review and meta-analysis.
Uchino M; Ikeuchi H; Hata K; Minagawa T; Horio Y; Kuwahara R; Nakamura S; Watanabe K; Saruta M; Fujii T; Kobayashi T; Sugimoto K; Hirai F; Esaki M; Hiraoka S; Matsuoka K; Shinzaki S; Matsuura M; Inoue N; Nakase H; Watanabe M
J Gastroenterol Hepatol; 2021 Apr; 36(4):864-872. PubMed ID: 33002235
[TBL] [Abstract][Full Text] [Related]
10. Anti-TNFα agents are the best choice in preventing postoperative Crohn's disease: A meta-analysis.
Erős A; Farkas N; Hegyi P; Szabó A; Balaskó M; Veres G; Czakó L; Bajor J; Alizadeh H; Rakonczay Z; Mikó A; Habon T; Erőss B; Bérczi B; Sarlós P
Dig Liver Dis; 2019 Aug; 51(8):1086-1095. PubMed ID: 31278016
[TBL] [Abstract][Full Text] [Related]
11. Previous Exposure to Multiple Anti-TNF Is Associated with Decreased Efficiency in Preventing Postoperative Crohn's Disease Recurrence.
Collins M; Sarter H; Gower-Rousseau C; Koriche D; Libier L; Nachury M; Cortot A; Zerbib P; Blanc P; Desreumaux P; Colombel JF; Peyrin-Biroulet L; Pineton de Chambrun G
J Crohns Colitis; 2017 Mar; 11(3):281-288. PubMed ID: 27578800
[TBL] [Abstract][Full Text] [Related]
12. Comparative Efficacy of Anti-TNF Therapies For The Prevention of Postoperative Recurrence of Crohn's Disease: A Systematic Review and Network Meta-Analysis of Prospective Trials.
Bakouny Z; Yared F; El Rassy E; Jabbour R; Hallit R; Khoury N; Honein K; Bou Jaoude J
J Clin Gastroenterol; 2019 Jul; 53(6):409-417. PubMed ID: 29517709
[TBL] [Abstract][Full Text] [Related]
13. Quantifying the rate of recurrence of postoperative Crohn's disease with biological therapy. A meta-analysis.
Jain SR; Ow ZGW; Chin YH; Lim WH; Kong G; Tham HY; Wong NW; Chong CS; Foo FJ; Chan WPW
J Dig Dis; 2021 Jul; 22(7):399-407. PubMed ID: 34048153
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.
Behm BW; Bickston SJ
Cochrane Database Syst Rev; 2008 Jan; (1):CD006893. PubMed ID: 18254120
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy of pharmacologic interventions in preventing relapse of Crohn's disease after surgery: a systematic review and network meta-analysis.
Singh S; Garg SK; Pardi DS; Wang Z; Murad MH; Loftus EV
Gastroenterology; 2015 Jan; 148(1):64-76.e2; quiz e14. PubMed ID: 25263803
[TBL] [Abstract][Full Text] [Related]
16. The Risk of Relapse after Anti-TNF Discontinuation in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.
Gisbert JP; Marín AC; Chaparro M
Am J Gastroenterol; 2016 May; 111(5):632-47. PubMed ID: 27002797
[TBL] [Abstract][Full Text] [Related]
17. Systematic Review and Network Meta-Analysis of Medical Therapies to Prevent Recurrence of Post-Operative Crohn's Disease.
Burr NE; Hall B; Hamlin PJ; Selinger CP; Ford AC; O'Connor A
J Crohns Colitis; 2019 May; 13(6):693-701. PubMed ID: 30561586
[TBL] [Abstract][Full Text] [Related]
18. Anti -TNFα agents in preventing the postoperative recurrence of Crohn's disease: Do they still play a role in the biological era?
Liu C; Li N; Zhan S; Tian Z; Wu D; Li T; Zeng Z; Zhuang X
Expert Opin Biol Ther; 2021 Nov; 21(11):1509-1524. PubMed ID: 34350811
[TBL] [Abstract][Full Text] [Related]
19. Risk Prediction and Comparative Efficacy of Anti-TNF vs Thiopurines, for Preventing Postoperative Recurrence in Crohn's Disease: A Pooled Analysis of 6 Trials.
Beelen EMJ; Nieboer D; Arkenbosch JHC; Regueiro MD; Satsangi J; Ardizzone S; López-Sanromán A; Savarino E; Armuzzi A; Janneke van der Woude C; de Vries AC
Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2741-2752.e6. PubMed ID: 34687970
[TBL] [Abstract][Full Text] [Related]
20. How to manage difficult Crohn's disease: optimum delivery of anti-TNFs.
Krygier DS; Ko HH; Bressler B
Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):407-15. PubMed ID: 19673627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
